drugset

drugset / Trial / NCT00690482

Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT00690482 ↗

Phase 2 Completed 118 enrolled AstraZeneca

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to study efficacy and safety of AZD1981 in patients with Chronic Obstructive Pulmonary Disease

Timeline

Start: 2008-05
Primary completion: 2008-12
Completion: 2008-12

Publications

Snell N, Foster M, Vestbo J. Efficacy and safety of AZD1981, a CRTH2 receptor antagonist, in patients with moderate to severe COPD. Respir Med. 2013 Nov;107(11):1722-30. doi: 10.1016/j.rmed.2013.06.006. Epub 2013 Jul 1.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AZD1981	Small molecule	1000 mg	Oral

Indications